CARBAMAZEPINE
- Product NDC
- 68071-4313
- 11-digit product format
- 680714313
- Labeler code
- 68071
- Product ID
- 68071-4313_bb7a27e8-229b-21d2-e053-2995a90a0068
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA075948
- Marketing category
- ANDA
- Marketing start
- 2002-09-01
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4313-1 | 68071431301 | 120 TABLET in 1 BOTTLE (68071-4313-1) | 120 tablet | 2018-03-07 | 0000-00-00 | No | No | Current |
| 68071-4313-3 | 68071431303 | 30 TABLET in 1 BOTTLE (68071-4313-3) | 30 tablet | 2018-03-07 | 0000-00-00 | No | No | Current |
| 68071-4313-6 | 68071431306 | 60 TABLET in 1 BOTTLE (68071-4313-6) | 60 tablet | 2018-03-07 | 0000-00-00 | No | No | Current |
| 68071-4313-9 | 68071431309 | 90 TABLET in 1 BOTTLE (68071-4313-9) | 90 tablet | 2018-03-07 | 0000-00-00 | No | No | Current |